Management of Asymptomatic Hyperuricemia Without Gout
A serum urate level of 6.5 mg/dL does not meet the American College of Rheumatology (ACR) definition of asymptomatic hyperuricemia used in its urate-lowering therapy (ULT) recommendation because that definition requires serum urate ≥6.8 mg/dL. [1]
In patients with asymptomatic hyperuricemia as defined by the ACR, initiation of ULT is conditionally recommended against. [2]
Serum Urate Threshold Relevant to Guideline-Based ULT
ACR defines asymptomatic hyperuricemia as serum urate (SU) concentration ≥6.8 mg/dL with no prior gout flares or subcutaneous tophi. [1]
A serum urate level of 6.5 mg/dL is below this threshold. [1]
Urate-Lowering Therapy Recommendation for Asymptomatic Hyperuricemia
Initiating ULT is conditionally recommended against in patients with asymptomatic hyperuricemia (no prior gout flares or subcutaneous tophi). [2]
Monotherapy and Combination Therapy Considerations
ULT is not recommended for initiation in asymptomatic hyperuricemia under the ACR guideline framework. [2]
Combination strategies with multiple ULT agents are therefore not indicated for asymptomatic hyperuricemia. [2]
Indications Where ULT May Be Considered Instead
ACR recommendations in this guideline document are targeted to patients with gout. [2]
ULT initiation is therefore addressed under gout-specific indications rather than asymptomatic hyperuricemia without gout manifestations. [2]
Common Pitfalls to Avoid
A pitfall is assuming that an elevated serum urate level alone mandates ULT in the absence of gout. [2]
Targets or Goals of Therapy
Serum urate targets are addressed for patients requiring ULT for gout indications. [2]
No urate target is established for initiating ULT in asymptomatic hyperuricemia because initiation is conditionally recommended against. [2]